ADHD Medication UK For Adults
Celebrities like Sue Perkins and Jonny Vegas have spoken out about their ADHD diagnosis, which has raised awareness and increased demand for medication. Specialist psychiatrists prescribe ADHD meds and closely monitor side effects to find the most effective dose for each patient.
The first type is a stimulant such as methylphenidate or lisdexamfetamine. Atomoxetine (Strattera) is also approved for treating ADHD however it functions differently and takes longer to take effect.
Stimulants
In the UK, stimulants can be used to treat ADHD. They work by changing levels of neurotransmitters inside the brain in order to improve attention and decrease hyperactivity. Psychologists carefully adjust the dosage of medications to find the right balance for each person. There are many different stimulant types, such as amphetamines (such as Ritalin) and methylphenidates. Non-stimulants are also used. Dexamfetamine, atomoxetine, and other stimulants are frequently used. However an investigation from the past suggests that they could be less effective than amphetamines and methylphenidate.
managing adhd without medication of medication is an integral part of treatment. The majority of people who use medication do so to complement psychological interventions. Psychotherapy can help a person learn healthy coping strategies and break old patterns of behavior. Some people opt not to take any medication. The use of medication is not an absolute solution. In the UK the UK, talk therapy is recommended as first option for adults suffering from ADHD and is typically offered alongside medication.
The number of people who are receiving ADHD medication has increased by twofold since the start of the Covid pandemic, and is now higher than the number of children who are prescribed these medications. This increase is partly due to people whose symptoms had previously been ignored or not diagnosed, but it is also likely that the recent restrictions on health resources especially for psychological services, have caused some patients to be offered pharmacological treatment before they could have been assessed.
On the NHS there are five central nervous systems (CNS) and ADHD medicines that are available, with amphetamines or methylphenidate being the most frequently prescribed. They are typically prescribed as short-acting tablets that last for a couple of hours or as a tablet with a slow release that is taken daily (also called modified or immediate release). A recent study suggests amphetamines, such as lisdexamfetamine should be the preferred treatment for adults with ADHD. The medication is highly effective and has a low risk of serious side effects, and costs the NHS just PS104m a year to prescribe.
Despite these obvious benefits, it is not common for stigma to remain especially in the neurodiversity communities where it can be observed. This is reflected in negative beliefs that divide people with ADHD into 'good' and 'bad" people. The 'good' people are those who do not take medication and manage their symptoms with no medication, while the 'bad' ones depend on medication to relieve their symptoms. This could be a problem to those seeking assistance, making it harder to access services and support.
As with all medications, there are risks associated with them, but the evidence supports the use of ADHD medications as an important part of treatment for ADHD. The risk of serious side effects is very low. They can be further reduced by following a carefully titrated process, ensuring that the medication is of the appropriate strength and observing any adverse effects regularly in the early stages of treatment. In addition, environmental modifications can reduce the impact of ADHD. This could include things like seating arrangements, making sure that the area is quiet and free of distractions and using a timer for schedule breaks, optimizing work or education for shorter periods of focus with a shift between activities, and utilising teaching assistants where feasible.